The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine"
BMJ
.
2021 May 17:373:n1249.
doi: 10.1136/bmj.n1249.
Authors
Gregg Gonsalves
1
,
Gavin Yamey
2
Affiliations
1
Public Health Modeling Unit and Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
2
Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.
PMID:
34001498
DOI:
10.1136/bmj.n1249
No abstract available